Cohlhepp Ryan Insider Trading Activity
Cohlhepp Ryan has been net-selling over the last 12 months with 0 purchases and 22 sales across 1 company.
BCAX is the most-traded position with 22 trades. The largest single transaction was a sale of BCAX for $433K on Oct 6, 2025.
Performance Scorecard
Forward stock performance after each transaction by Cohlhepp Ryan. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | +3.9% | 55% | 22 |
| 90 days | — | -6.3% | 40% | 20 |
| 120 days | — | -16.8% | 33% | 18 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersBCAX · Bicara Therapeutics Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Cohlhepp Ryan bought and sold BCAX.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
May 15, 2026 | BCAX | Sell | 8,000 | $20.29 | $162K | −3.9% | COO | |
May 15, 2026 | BCAX | Sell | 4,500 | $20.29 | $91K | −2.3% | COO | |
Apr 15, 2026 | BCAX | Sell | 8,000 | $23.01 | $184K | −3.8% | COO | |
Apr 15, 2026 | BCAX | Sell | 4,500 | $23.01 | $104K | −2.2% | COO | |
Mar 16, 2026 | BCAX | Sell | 8,000 | $19.66 | $157K | −3.8% | COO | |
Mar 16, 2026 | BCAX | Sell | 4,500 | $19.66 | $88K | −2.2% | COO | |
Mar 3, 2026 | BCAX | Sell | 12,892 | $18.16 | $234K | −5.8% | COO | |
Mar 3, 2026 | BCAX | Sell | 4,500 | $18.16 | $82K | −2.1% | COO | |
Feb 25, 2026 | BCAX | Sell | 3,108 | $18.04 | $56K | −1.5% | COO | |
Feb 25, 2026 | BCAX | Sell | 523 | $18.04 | $9K | −0.2% | COO | |
Jan 22, 2026 | BCAX | Sell | 3,828 | $18.10 | $69K | −1.8% | COO | |
Jan 15, 2026 Filed 3d late | BCAX | Sell | 149 | $18.02 | $3K | −0.1% | COO | |
Dec 15, 2025 | BCAX | Sell | 4,500 | $18.68 | $84K | −2.3% | COO | |
Dec 15, 2025 | BCAX | Sell | 8,000 | $18.68 | $149K | −4.0% | COO | |
Nov 21, 2025 | BCAX | Sell | 8,000 | $18.05 | $144K | −3.9% | COO | |
Nov 21, 2025 | BCAX | Sell | 4,500 | $18.05 | $81K | −2.3% | COO | |
Oct 15, 2025 | BCAX | Sell | 4,500 | $18.16 | $82K | −2.2% | COO | |
Oct 15, 2025 | BCAX | Sell | 8,000 | $18.16 | $145K | −3.8% | COO | |
Oct 7, 2025 | BCAX | Sell | 8,000 | $18.06 | $144K | −3.7% | COO | |
Oct 7, 2025 | BCAX | Sell | 2,900 | $18.06 | $52K | −1.4% | COO | |
Oct 6, 2025 | BCAX | Sell | 24,000 | $18.06 | $433K | −9.8% | COO | |
Oct 6, 2025 | BCAX | Sell | 15,600 | $18.06 | $282K | −7.1% | COO |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | 22 | $2.8M |
Other insiders at Bicara Therapeutics Inc.
4 other tracked filers at BCAX.